Congress’ Medicare Pay advisors are continuing discussions on potential policy options to reduce Part B drug spending, including an option that would eliminate drug add-on pay for providers to incentivize doctors to treat patients with lower cost drugs. The policy is one of three the Medicare Payment Advisory Commission (MedPAC) aims to turn into draft recommendations on reducing Part B drug spending ahead of this year’s June report to Congress. MedPAC staff told commissioners at a Jan. 13 meeting that...